Business Insider India has updated its Privacy and Cookie policy. We use cookies to ensure that we give you the better experience on our website. If you continue without changing your settings, we\'ll assume that you are happy to receive all cookies on the Business Insider India website. However, you can change your cookie setting at any time by clicking on our Cookie Policy at any time. You can also see our Privacy Policy.
Theranos is reportedly stopping its signature blood-testing method under pressure from federal regulators
Theranos is reportedly stopping its signature blood-testing method under pressure from federal regulators
Bryan LoganOct 16, 2015, 08:34 IST
CBS This Morning via YouTube / Screengrab
Laboratory startup Theranos has reportedly stopped using finger pricks to collect blood samples for all except one of its tests, under pressure from federal regulators, The Wall Street Journal reports.
Advertisement
That follows months of scrutiny $10 billion Theranos and its CEO, Elizabeth Holmes, have faced regarding its signature blood-testing method, which was thought to potentially revolutionize that industry.
